ASPIRIN CURES ERYTHROMELALGIA AND CEREBROVASCULAR DISTURBANCES IN JAK2-THROMBOCYTHEMIA THROUGH PLATELET-CYCLOXYGENASE INHIBITION – MPN Research Foundation
ASPIRIN CURES ERYTHROMELALGIA AND CEREBROVASCULAR DISTURBANCES IN JAK2-THROMBOCYTHEMIA THROUGH PLATELET-CYCLOXYGENASE INHIBITION
MPNRF | April 28, 2021
To view the Abstract pg this article please click here.
Stay informed about MPN research & news!
Join our community to get the latest research, patient stories, and exclusive content delivered right to your inbox. Plus, when you subscribe, receive the latest NCCN guidelines and resources to support your journey.